Second, we showed that the same ASOs promote expression of full-length SMN protein in primary fibroblasts from a type I SMA patient; though significant, this effect appears subtle because of the relatively low transfection efficiency with these cells. The gene discussed is SMN2; the disease is spinal muscular atrophy, type 1.